GLP-1 users are losing weight but moving less
New ENDO 2026 data suggests GLP-1 users may be losing weight while moving less, which makes routine and support questions more important on provider pages.
The latest ENDO 2026 data is worth a pause if you are following GLP-1. In a wearable-tracker study of 753 adults with obesity, people lost weight after starting treatment, but their daily activity dropped as well.
Researchers tracked step counts and exercise minutes before and after treatment, then compared the pattern with what many people assume will happen once weight starts to fall. The results were not dramatic in the headline sense, but they were important: daily steps fell from 5,047 to 4,487, and time in moderate-to-vigorous exercise dropped from 28 minutes a day to 22.
That is a useful reminder that appetite change and movement do not always move in the same direction.
Why that matters
GLP-1 headlines often focus on appetite, dose and visible weight change. This study adds a different layer. If activity also falls, the long-term routine around treatment can become less predictable than the first before-and-after photo suggests. The biggest drops in activity were seen in men and in people already dealing with joint or muscle pain.
For Weight Loss Comparison, the useful question is how people actually live while using GLP-1 and whether provider support makes the day-to-day routine easier to keep in place.
What to look for on provider pages
- Clear follow-up and support rather than a one-line checkout flow.
- Maintenance and repeat-review information that explains what happens after the first order.
- Any guidance on dose changes, symptom management or when to seek clinical advice.
- Pricing that is easy to read without hiding the route or support structure.
What this means for the comparison pages
The best provider pages do more than repeat a headline price. They show how the route is supported if appetite changes, energy levels shift or the routine becomes harder to keep up. That is exactly where a comparison site can be useful.
For a current shortlist, start here: compare providers and then move to the provider pages if you want the route details as well.
Source: ScienceDaily / ENDO 2026. Published 18 June 2026.
Related articles
Important information
This website is an informational comparison hub. It does not prescribe, supply or sell prescription-only medicines. Suitability depends on a regulated clinical assessment.
Some links may be affiliate or commercial links. Commercial relationships must not change the way safety, eligibility, source checks or editorial context are presented.